The pharmacological aspects of the treatment of acromegaly

Pharmacol Res. 1996 Nov-Dec;34(5-6):247-68. doi: 10.1006/phrs.1996.0095.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acromegaly / drug therapy*
  • Acromegaly / metabolism
  • Acromegaly / pathology
  • Dopamine Agonists / therapeutic use
  • Growth Hormone / metabolism
  • Hemodynamics / drug effects
  • Humans
  • Octreotide / adverse effects
  • Octreotide / pharmacokinetics
  • Octreotide / therapeutic use
  • Peptides, Cyclic / adverse effects
  • Peptides, Cyclic / pharmacokinetics
  • Peptides, Cyclic / therapeutic use
  • Pituitary Neoplasms / pathology
  • Somatostatin / adverse effects
  • Somatostatin / analogs & derivatives
  • Somatostatin / pharmacokinetics
  • Somatostatin / therapeutic use

Substances

  • Dopamine Agonists
  • Peptides, Cyclic
  • lanreotide
  • Somatostatin
  • Growth Hormone
  • Octreotide